Once-Monthly Continuous Erythropoietin Receptor Activator (C.E.R.A.) in Patients with Hemodialysis-Dependent Chronic Kidney Disease: Pooled Data from Phase III Trials

INTRODUCTION: Erythropoiesis-stimulating agents and iron are commonly used in patients with chronic kidney disease with the aim of correcting anemia and maintaining stable hemoglobin levels. We analyzed pooled data from 13 studies with similar designs included in the Umbrella Continuous Erythropoiet...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Argitaratua izan da:Adv Ther
Egile Nagusiak: Locatelli, Francesco, Choukroun, Gabriel, Truman, Matt, Wiggenhauser, Alfons, Fliser, Danilo
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: Springer Healthcare 2016
Gaiak:
Original Research
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC4846713/
https://ncbi.nlm.nih.gov/pubmed/26965694
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s12325-016-0309-6
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak